Quantitative Methods to Study Protein Arginine Methyltransferase 1-9 Activity in Cells

被引:2
|
作者
Szewczyk, Magdalena M. [1 ]
Vu, Victoria [1 ]
Barsyte-Lovejoy, Dalia [1 ,2 ]
机构
[1] Univ Toronto, Struct Genom Consortium, Toronto, ON, Canada
[2] Univ Toronto, Dept Pharmacol & Toxicol, Toronto, ON, Canada
来源
JOVE-JOURNAL OF VISUALIZED EXPERIMENTS | 2021年 / 174期
基金
英国惠康基金;
关键词
SUBSTRATE-SPECIFICITY; ALLOSTERIC INHIBITOR; METHYLATION; POTENT; EWS;
D O I
10.3791/62418
中图分类号
O [数理科学和化学]; P [天文学、地球科学]; Q [生物科学]; N [自然科学总论];
学科分类号
07 ; 0710 ; 09 ;
摘要
Protein methyltransferases (PRMTs) catalyze the transfer of a methyl group to arginine residues of substrate proteins. The PRMT family consists of nine members that can monomethylate or symmetrically/asymmetrically dimethylate arginine residues. Several antibodies recognizing different types of arginine methylation of various proteins are available; thus, providing tools for the development of PRMT activity biomarker assays. PRMT antibody-based assays are challenging due to overlapping substrates and motif-based antibody specificities. These issues and the experimental setup to investigate the arginine methylation contributed by individual PRMTs are discussed. Through the careful selection of the representative substrates that are biomarkers for eight out of nine PRMTs, a panel of PRMT activity assays were designed. Here, the protocols for cellular assays quantitatively measuring the enzymatic activity of individual members of the PRMT family in cells are reported. The advantage of the described methods is their straightforward performance in any lab with cell culture and fluorescent western blot capabilities. The substrate specificity and chosen antibody reliability were fully validated with knockdown and overexpression approaches. In addition to detailed guidelines of the assay biomarkers and antibodies, information on the use of an inhibitor tool compound collection for PRMTs is also provided.
引用
收藏
页数:22
相关论文
共 50 条
  • [41] Protein arginine methyltransferase 1 is required for maintenance of normal adult hematopoiesis
    Zhu, Lei
    He, Xin
    Dong, Haojie
    Sun, Jie
    Wang, Hanying
    Zhu, Yinghui
    Huang, Feiteng
    Zou, Jingying
    Chen, Zexin
    Zhao, Xiaoying
    Li, Ling
    INTERNATIONAL JOURNAL OF BIOLOGICAL SCIENCES, 2019, 15 (13): : 2763 - 2773
  • [42] A combinatorial approach to characterize the substrate specificity of protein arginine methyltransferase 1
    Bicker, Kevin L.
    Obianyo, Obiamaka
    Rust, Heather L.
    Thompson, Paul R.
    MOLECULAR BIOSYSTEMS, 2011, 7 (01) : 48 - 51
  • [43] Structural basis for Sfm1 functioning as a protein arginine methyltransferase
    Lv, Fengjuan
    Zhang, Tianlong
    Zhou, Zhen
    Gao, Shuaixin
    Wong, Catherine C. L.
    Zhou, Jin-Qiu
    Ding, Jianping
    CELL DISCOVERY, 2015, 1
  • [44] Protein arginine methyltransferase 5 is a key regulator of the MYCN oncoprotein in neuroblastoma cells
    Park, Ji Hyun
    Szemes, Marianna
    Vieira, Gabriella Cunha
    Melegh, Zsombor
    Malik, Sally
    Heesom, Kate J.
    Von Wallwitz-Freitas, Laura
    Greenhough, Alexander
    Brown, Keith W.
    Zheng, Y. George
    Catchpoole, Daniel
    Deery, Michael J.
    Malik, Karim
    MOLECULAR ONCOLOGY, 2015, 9 (03) : 617 - 627
  • [45] Histone H4-based peptoids are inhibitors of protein arginine methyltransferase 1 (PRMT1)
    Mann, Sarah A.
    DeMart, Megan K.
    May, Braidy
    Causey, Corey P.
    Knuckley, Bryan
    BIOCHEMICAL JOURNAL, 2020, 477 (16) : 2971 - 2980
  • [46] Protein Arginine Methyltransferase 5 (PRMT5) Mutations in Cancer Cells
    Rasheed, Shayaan
    Bouley, Renee A.
    Yoder, Ryan J.
    Petreaca, Ruben C.
    INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES, 2023, 24 (07)
  • [47] Inhibition of protein arginine methyltransferase 1 alleviates liver fibrosis by attenuating the activation of hepatic stellate cells in mice
    Yan, Fang-Zhi
    Qian, Hui
    Liu, Fang
    Ding, Chen-Hong
    Liu, Shu-Qing
    Xiao, Meng-Chao
    Chen, Shi-Jie
    Zhang, Xin
    Luo, Cheng
    Xie, Wei-Fen
    FASEB JOURNAL, 2022, 36 (09)
  • [48] A Remodeled Protein Arginine Methyltransferase 1 ( PRMT1) Generates Symmetric Dimethylarginine
    Gui, Shanying
    Gathiaka, Symon
    Li, Jun
    Qu, Jun
    Acevedo, Orlando
    Hevel, Joan M.
    JOURNAL OF BIOLOGICAL CHEMISTRY, 2014, 289 (13) : 9320 - 9327
  • [49] Naturally occurring cancer-associated mutations disrupt oligomerization and activity of protein arginine methyltransferase 1 (PRMT1)
    Price, Owen M.
    Thakur, Abhishek
    Ortolano, Ariana
    Towne, Arianna
    Velez, Caroline
    Acevedo, Orlando
    Hevel, Joan M.
    JOURNAL OF BIOLOGICAL CHEMISTRY, 2021, 297 (05)
  • [50] Roles of protein arginine methyltransferase 1 (PRMT1) in brain development and disease
    Hashimoto, Misuzu
    Fukamizu, Akiyoshi
    Nakagawa, Tsutomu
    Kizuka, Yasuhiko
    BIOCHIMICA ET BIOPHYSICA ACTA-GENERAL SUBJECTS, 2021, 1865 (01):